Compare · BTSG vs OPCH
BTSG vs OPCH
Side-by-side comparison of BrightSpring Health Services Inc. (BTSG) and Option Care Health Inc. (OPCH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BTSG and OPCH operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- BTSG is the larger of the two at $12.34B, about 2.6x OPCH ($4.68B).
- Over the past year, BTSG is up 105.5% and OPCH is up 12.3% - BTSG leads by 93.1 points.
- OPCH has been more active in the news (4 items in the past 4 weeks vs 1 for BTSG).
- BTSG has more recent analyst coverage (23 ratings vs 17 for OPCH).
- Company
- BrightSpring Health Services Inc.
- Option Care Health Inc.
- Price
- $60.90-2.30%
- $31.20-0.11%
- Market cap
- $12.34B
- $4.68B
- 1M return
- +7.56%
- +27.27%
- 1Y return
- +105.47%
- +12.33%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2024
- News (4w)
- 1
- 4
- Recent ratings
- 23
- 17
Option Care Health Inc.
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides immunoglobulin infusion therapies for the treatment of immune deficiencies; anti-infective therapies and services; home infusion services to treat heart failures; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders; and immunoglobulin infusion therapies. It also offers infusion therapies for bleeding disorders; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications. In addition, the company offers therapies that women need to survive and thrive through high-risk pregnancies; treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; and nursing services. The company is headquartered in Bannockburn, Illinois.
Latest BTSG
- BrightSpring Health Services, Inc. to Announce Third Quarter 2026 Financial Results on October 30, 2026
- President, PharMerica Greenwell Scott A. exercised 11,973 shares at a strike of $22.27 and sold $874,383 worth of shares (15,099 units at $57.91), decreasing direct ownership by 9% to 31,246 units (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by BrightSpring Health Services Inc.
- SEC Form 10-Q filed by BrightSpring Health Services Inc.
- BrightSpring Health Services Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance
- Officer Rousseau Jon B covered exercise/tax liability with 56,319 shares, decreasing direct ownership by 5% to 1,138,184 units (SEC Form 4) to cover withholding tax
- BrightSpring Health Services Set to Join S&P MidCap 400 and Karman Holdings to Join S&P SmallCap 600
- Guggenheim initiated coverage on BrightSpring Health Services with a new price target
- Raymond James initiated coverage on BrightSpring Health Services with a new price target
Latest OPCH
- SEC Form DEFA14A filed by Option Care Health Inc.
- SEC Form DEFA14A filed by Option Care Health Inc.
- SEC Form 8-K filed by Option Care Health Inc.
- CD&R and McKesson Corporation Sign Agreement to Acquire Option Care Health
- Option Care Health to Participate in Upcoming Investor Conferences
- Option Care Health downgraded by Deutsche Bank with a new price target
- SEC Form 10-Q filed by Option Care Health Inc.
- Option Care Health Announces Financial Results For The Second Quarter Ended June 30, 2026
- Option Care Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Option Care Health downgraded by Stephens with a new price target